BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20056895)

  • 1. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
    Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
    Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered serum N-glycomics in chronic hepatitis B patients.
    Gui HL; Gao CF; Wang H; Liu XE; Xie Q; Dewaele S; Wang L; Zhuang H; Contreras R; Libert C; Chen C
    Liver Int; 2010 Feb; 30(2):259-67. PubMed ID: 19951379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
    Itoh N; Sakaue S; Nakagawa H; Kurogochi M; Ohira H; Deguchi K; Nishimura S; Nishimura M
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1069-77. PubMed ID: 17666489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.
    Attallah AM; Shiha GE; Ismail H; Mansy SE; El-Sherbiny R; El-Dosoky I
    Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
    Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
    Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
    Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "pseudo-cholangiocarcinoma sign" in patients with cavernous transformation of the portal vein and its effect on the serum alkaline phosphatase and bilirubin levels.
    Bayraktar Y; Balkanci F; Ozenc A; Arslan S; Koseoglu T; Ozdemir A; Uzunalimoglu B; Telatar H; Gurakar A; Van Thiel DH
    Am J Gastroenterol; 1995 Nov; 90(11):2015-9. PubMed ID: 7485013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum activin-A differentiates alcoholic from cirrhosis of other aetiologies.
    Voumvouraki A; Notas G; Koulentaki M; Georgiadou M; Klironomos S; Kouroumalis E
    Eur J Clin Invest; 2012 Aug; 42(8):815-22. PubMed ID: 22304651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis.
    Aoyagi Y; Saitoh A; Suzuki Y; Igarashi K; Oguro M; Yokota T; Mori S; Suda T; Isemura M; Asakura H
    Hepatology; 1993 Jan; 17(1):50-2. PubMed ID: 7678576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum laminin in chronic alcoholic liver disease: its value in the estimation of the degree of fibrosis].
    González Reimers E; Santolaria Fernández F; Rodríguez Rodríguez E; Rodríguez Moreno F; Milena Abril A; Martínez-Riera A; García-Castro C
    Rev Esp Enferm Dig; 1996 Apr; 88(4):241-5. PubMed ID: 9004793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.